Personal Health  
comments_image Comments

5 Shady Ways Big Pharma May Be Influencing Your Doctor

Pharma can entice doctors to prescribe its expensive patent drugs, even when they are dangerous.
 
 
Share
 
 
 
 

Until 2010, when the  Physician Payments Sunshine Act passed, requiring doctors to disclose payments, the only thing better than working for Pharma was being a doctor wined and dined by Pharma.

Pfizer jetted 5,000 doctors to Caribbean resorts where they enjoyed massages, golf and $2,000 honoraria charges to sell its painkiller Bextra ( withdrawn from the market in 2005 for heart risks). GSK sent doctors to lavish resorts to promote Wellbutrin, the  Justice Department chargedJohnson & Johnson bestowed trips, perks and honoraria on Texas Medicaid officials to get its drug Risperdal preferred on the formulary, a state lawsuit charged. Bristol-Myers Squibb enticed doctors to prescribe its drugs with access to the Los Angeles Lakers and luxury box suites for their games, California regulators say. In China  GSK is charged with using a network of 700 middlemen and travel agencies to bribe doctors with cash and sexual favors, and  Victory Pharma, an opioid drugs maker, was charged with treating doctors to strip shows. Nice.

Of course, Pharma reps did as well as the doctors. Thanks to their Barbie and Ken doll looks and the free samples, gifts and lunches they would bring medical staff, they would often waltz in to see the doctor before the sick and waiting patients. Some had their own lounges at medical offices. Since the 2010 sunshine law, part of the Affordable Care Act, went into effect in 2013, drug companies must display the doctors and groups they pay on their websites. That includes their payments to faux grassroots groups like Go Red For Women and the National Alliance on Mental Illness, or NAMI, which are widely seen as Pharma fronts. But will it make a difference? For years, doctors have also begun presentations with slides detailing their Pharma funding but it doesn't seem to alter their credibility or audience cynicism.

When it comes to acknowledging the influence of gifts and money on behavior, doctors, like everyone else, suffer from self-delusion. Most say they believe it affects the other guy, not them, and many become offended at the idea that they are "for sale."

"My prescribing never changes because once a month a drug rep brings in a tray of sandwiches," Maria Carmen Wilson told the  Tampa Bay Times. (Wilson was Eli Lilly's number-two earner in Florida in 2009, the paper reports.) It's tempting to ask such doctors that if the largesse doesn't affect them, when was the last time they prescribed the competitor's pill? Would anyone believe or even read the journalism of a reporter who accepted an honorarium or speaker's fee from the subject she reported on? Even if she claimed it didn't influence her?

Trips to resorts and strip clubs will likely continue to diminish under the Physician Payments Sunshine Act, but there are many other ways, often sneaky, that Pharma can entice doctors to prescribe its expensive, patent drugs.

1. Spying on Prescribing

Like the NSA spying program, shameless spying on doctors' prescribing habits spares almost no one. Recently, the full sweep of IMS Health Holdings' prescription data mining was revealed by  ProPublica, which reported that its collection includes over 85 percent of the world's prescriptions and "comprehensive, anonymous medical records for 400 million patients." In 2007, there was a backlash against another seller of medical information: the AMA itself. By selling the names, office addresses and practice types of almost every doctor in the US to marketing firms the AMA netted almost $50 million a year, the American Medical Student Association and the National Physicians Alliance charged at  the AMA's convention. The database of 900,000 doctors does not violate privacy, counters the AMA, since  doctors can opt out.

 
See more stories tagged with: